This article is more than 5 years old. Information may no longer be current.

New aspheric lens, other technologies make debut

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

STOCKHOLM, Sweden — A new line of aspheric monofocal IOLs using "Modulation Transfer Function" was introduced, along with numerous devices, at the European Society of Cataract & Refractive Surgeons meeting.

Carl Zeiss Meditec introduced the first members of its ZEISS Optic (ZO) family, the XL Stabi ZO and the Invent ZO at a press conference here. The new lenses, which are based upon the Liou and Brennan eye model, widely reduce and control spherical aberrations with low sensitivity to decentration and tilt. The lens is based on the "Modulation Transfer Function" to perfect its relation to the optic and contrast sensitivity, according to information provided by the company.

The company will present preliminary results of a multi-center European clinical study of the Invent ZO and a marketing study of the XL Stabi ZO at the company's symposium at the ESCRS this week.

At a press conference at the meeting, Ulrich Krauss, president and CEO of Carl Zeiss Meditec, said the company will also launch other new technologies here as part of its effort to "combine and integrate technologies" in ophthalmology.

In addition to the ZO IOLs launched at the meeting, Carl Zeiss Meditec introduced or previewed the following technologies: the OPMI Lumera and OPMI Lumera T surgical microscopes with a new red reflex technology; the Cirrus HD-OCT, expanding the company's ocular coherence tomography (OCT) platforms to two; the IOLMaster with Advanced Technology Software Version 5, with faster and more improved movement; and VISUPAC Star, an archiving system that allows for the viewing and saving of diagnostic results at a single workstation.

Earlier this month, the company announced that it intended to acquire Acri.Tec AG for about $32.76 million. Mr. Krauss said in a company press release that the acquisition will increase the company's focus on IOL lenses, while it also expands into the ophthalmic surgery market, developing devices for glaucoma, retina and cataract surgery.

"As you can see, we're covering quite a bandwidth of applications in technology in ophthalmology," he said in the press release.